AnteoTech (ASX:ADO) ROCE % : -106.96% (As of Dec. 2024)

View and export this data going back to 2000. Start your Free Trial

What is AnteoTech ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. AnteoTech's annualized ROCE % for the quarter that ended in Dec. 2024 was -106.96%.

AnteoTech ROCE % Historical Data

The historical data trend for AnteoTech's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AnteoTech ROCE % Chart

AnteoTech Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

ROCE %

Get a 7-Day Free Trial

-116.01

-63.16

-73.61

-155.20

-229.17

AnteoTech Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
ROCE %	Get a 7-Day Free Trial															-113.84	-192.09	-268.00	-199.68	-106.96

AnteoTech ROCE % Calculation

AnteoTech's annualized ROCE % for the fiscal year that ended in Jun. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Jun. 2024 )		(A: Jun. 2023 )		(A: Jun. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Jun. 2024 )		(A: Jun. 2023 )		(A: Jun. 2024 )
	=	-12.766	/	( ( (5.362 - 1.804)	+	(9.381 - 1.798) )	/ 2 )
	=	-12.766	/	( (3.558	+	7.583)	/ 2 )
	=	-12.766	/	5.5705
	=	-229.17 %

AnteoTech's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Jun. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Jun. 2024 )		(Q: Dec. 2024 )
	=	-9.44	/	( ( (9.381 - 1.798)	+	(11.538 - 1.469) )	/ 2 )
	=	-9.44	/	( ( 7.583	+	10.069 )	/ 2 )
	=	-9.44	/	8.826
	=	-106.96 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2024) EBIT data.

AnteoTech (ASX:ADO) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

AnteoTech ROCE % Related Terms

Thank you for viewing the detailed overview of AnteoTech's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

AnteoTech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AnteoTech Ltd (ASX:ADO) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

4/26 Brandl Street, Eight Mile Plains, Brisbane, QLD, AUS, 4113

Website

https://www.anteotech.com

AnteoTech Ltd is a biotechnology company engaged in the development of specialty products and services and end-user diagnostic products focused on the Battery and Life Science diagnostics markets. Its key areas are the Energy and Life Science Division. The company is developing four products named AnteoX, Ultranode, AnteoBind NXT, and AnteoBind these products are used in the energy, diagnostic, and medical device markets. The company currently has a single segment which is the development of the AnteoTech IP.

AnteoTech Headlines

No Headlines